Global Reporting Initiative

Universal Standards

RD Saúde’s operations focus on delivering integrated health solutions. The company’s activities include the retail sale of drugs, perfumery, personal hygiene and beauty products, cosmetics, dermocosmetics, and specialty drugs. The products we sell are sourced from approximately 840 suppliers (740 direct and 100 private labels), and the downstream entities include customers and other companies within the Group (4Bio, Vitat, Cuco Health, Manipulaê, RD Ads, Amplimed, Healthbit, and SafePill). Other business relationships include two joint ventures (JVs): Stix, a rewards and points platform created in partnership between RD Saúde (33.3% share) and GPA (66.7% share). The second JV is Labi Exames, focused on laboratory tests, screenings, check-ups, and vaccines, with physical units and home care services (we hold a 23.61% share). There have been no significant changes from the previous year.